Targeting neurotensin as a potential novel approach for the treatment of autism

被引：26

作者：

Ghanizadeh, Ahmad ^{[1
,2
]}

机构：

[1] Shiraz Univ Med Sci, Hafez Hosp, Res Ctr Psychiat & Behav Sci, Shiraz, Iran

[2] Shiraz Univ Med Sci, Hafez Hosp, Dept Psychiat, Shiraz, Iran

来源：

JOURNAL OF NEUROINFLAMMATION | 2010年 / 7卷

关键词：

PREFRONTAL CORTEX; TRANSMISSION; GLUTAMATE; RECEPTOR; MODULATION;

D O I：

10.1186/1742-2094-7-58

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The pathophysiology of autism remains obscure. Recently, serum neurotensin levels in children with autistic disorder have been found to be higher than those of normal children. Neurotensin is known to intensify neuronal NMDA-mediated glutamate signaling, which may cause apoptosis in autism. Further, an imbalance of glutamate/GABAergic system in autism has been described. These observations lead to a postulate that neurotensin may accentuate the hyperglutaminergic state in autism, leading to apoptosis. Targeting neurotensin might be a possible novel approach for the treatment of autism.

引用

页数：2

共 50 条

[31] Targeting KIR as a novel approach to improve CAR-NK cell function [J].

Graham, Lara, V ;

Fisher, Jack G. ;

Khakoo, Salim I. ;

Blunt, Matthew D. .

JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2023, 7 (04) :230-235

[32] Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease [J].

Thapa, Dinesh ;

Ghimire, Anjali ;

Warne, Leon N. ;

Carlessi, Rodrigo .

PHARMACEUTICALS, 2025, 18 (04)

[33] Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy? [J].

Kim, Youn Ju ;

Lim, Joo Hyun ;

Kim, Eun Ran .

MEDICAL HYPOTHESES, 2025, 195

[34] A novel potential therapeutic avenue for autism: Design, synthesis and pharmacophore generation of SSRIs with dual action [J].

Ghoneim, Ola M. ;

Ibrahim, Diaa A. ;

El-Deeb, Ibrahim M. ;

Lee, So Ha ;

Booth, Raymond G. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) :6714-6723

[35] Neurotensin-Like Peptides as Potential Antipsychotics: Modulation of the Serotonin System [J].

Kost, N. V. ;

Meshavkin, V. K. ;

Khashaba, E. Yu. ;

Sokolov, O. Yu. ;

Voevodina, M. E. ;

Zolotarev, Yu. A. ;

Andreeva, L. A. ;

Myasoedov, N. F. .

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 157 (06) :738-741

[36] Potential roles of neurotensin on cognition in conditions of obese-insulin resistance [J].

Saiyasit, Napatsorn ;

Sripetchwandee, Jirapas ;

Chattipakorn, Nipon ;

Chattipakorn, Siriporn C. .

NEUROPEPTIDES, 2018, 72 :12-22

[37] Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation [J].

Bashashati, M. ;

Nasser, Y. ;

Keenan, C. M. ;

Ho, W. ;

Piscitelli, F. ;

Nalli, M. ;

Mackie, K. ;

Storr, M. A. ;

Di Marzo, V. ;

Sharkey, K. A. .

BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (12) :3099-3111

[38] Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder [J].

Wang, Luyao ;

Xu, Rongyang ;

Huang, Chengying ;

Yi, Guozhong ;

Li, Zhiyong ;

Zhang, Huayang ;

Ye, Rongxu ;

Qi, Songtao ;

Huang, Guanglong ;

Qu, Shanqiang .

GENERAL PSYCHIATRY, 2023, 36 (05)

[39] Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins [J].

Griebel, Guy .

CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (26) :3807-3812

[40] Targeting metabotropic glutamate receptors for novel treatments of schizophrenia [J].

Maksymetz, James ;

Moran, Sean P. ;

Conn, P. Jeffrey .

MOLECULAR BRAIN, 2017, 10

← 1 2 3 4 5 →